These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 4679040)
1. [Parapharmaceutical advertising and its control (law no. 72-7 of 3 January 1972)]. Doll PJ Med Leg Dommage Corpor; 1972; 5(4):359-62. PubMed ID: 4679040 [No Abstract] [Full Text] [Related]
2. [Away with quacks. Law no. 72-7 of 3 January 1972]. Doll PJ Nouv Presse Med; 1972 Jan; 1(5):353-4. PubMed ID: 4334558 [No Abstract] [Full Text] [Related]
3. [The lying advertisement of pharmaceuticals]. Dillemann G; Plat M Ann Pharm Fr; 1970 Mar; 28(3):223-33. PubMed ID: 5429066 [No Abstract] [Full Text] [Related]
5. Advertising and the law: ten years later. Griffenhagen G Am Pharm; 1991 Aug; NS31(8):43-4. PubMed ID: 1927899 [No Abstract] [Full Text] [Related]
6. [Ethics of medical advertising]. de Oliveira E Hospital (Rio J); 1969 Oct; 76(4):1385-94. PubMed ID: 5308117 [No Abstract] [Full Text] [Related]
7. [On the nature and phenomena of modern quackery and forth-coming drug legislation]. SCHUEPPERT R Dtsch Med J; 1960 Nov; 11():534-6. PubMed ID: 13748759 [No Abstract] [Full Text] [Related]
8. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium. Garbutt BJ; Hofmann ME Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558 [No Abstract] [Full Text] [Related]
9. [Rules for the advertising of special preparations? Suggestion for a safe standardization]. Naess K Tidsskr Nor Laegeforen; 1968 Mar; 88(5):347-9. PubMed ID: 5671518 [No Abstract] [Full Text] [Related]
11. [Problems of youth, or the revolt of the phlebologist]. Marmasse J Phlebologie; 1967; 20(3):309-11. PubMed ID: 6060674 [No Abstract] [Full Text] [Related]
12. From quackery to qualification: Arkansas medical and drug legislation, 1881-1909. Moyers D Ark Hist Q; 1976; 35():3-26. PubMed ID: 11616627 [No Abstract] [Full Text] [Related]
13. The regulation of health quackery. Young JH Pharm Hist; 1984; 26(1):3-12. PubMed ID: 11611334 [No Abstract] [Full Text] [Related]
14. [Quackery in Sweden; comments and date with reference to current discussion]. THOMASSON CG Soc Med Tidskr; 1952 Apr; 29(4):82-92; contd. PubMed ID: 14950355 [No Abstract] [Full Text] [Related]
15. [The advertising of medicinal products to the public in Poland--legislative, ethical, health and social concerns]. Cianciara D Przegl Epidemiol; 2004; 58(3):555-63. PubMed ID: 15730020 [TBL] [Abstract][Full Text] [Related]
16. [Proposed law on medical and pharmaceutical studies. Statement of the motives]. LARC Med; 1982 Oct; 2(9):788-92. PubMed ID: 7162282 [No Abstract] [Full Text] [Related]
17. "Quackery" outlawed in registered pharmacy. Campbell D BMJ; 1997 Sep; 315(7109):625. PubMed ID: 9310557 [No Abstract] [Full Text] [Related]
18. Quackery. A thoroughly modern problem. Uretsky S; Birdsall C Am J Nurs; 1986 Sep; 86(9):1030-3. PubMed ID: 3638913 [No Abstract] [Full Text] [Related]
19. Should the FDA control medical devices? Ariz Med; 1968 Sep; 25(9):814-5. PubMed ID: 5680263 [No Abstract] [Full Text] [Related]
20. The economic wisdom of regulating pharmaceutical "freebies". Fisher SH Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416 [No Abstract] [Full Text] [Related] [Next] [New Search]